↓ Skip to main content

Cochrane Database of Systematic Reviews

Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
4 X users

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
199 Mendeley
Title
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd000514.pub3
Pubmed ID
Authors

Joanna M Wardlaw, Panos Koumellis, Ming Liu

Abstract

Stroke is a leading cause of death and disability world wide. Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is licensed for treatment of acute ischaemic stroke in the early hours after symptom onset. It has been shown in randomised controlled trials (RCTs) and the 2009 Cochrane review of thrombolysis for acute ischaemic stroke to reduce dependency but at the increased risk of intracranial haemorrhage. Methods to reduce the risk of haemorrhage while retaining or enhancing the benefit could increase the use of thrombolytic treatment. While most available information comes from RCTs of intravenous rt-PA at 0.9 mg/kg, it is possible that other doses, drugs and other routes of administration might increase benefit and reduce the hazard.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Russia 1 <1%
Singapore 1 <1%
Brazil 1 <1%
Unknown 194 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 14%
Student > Master 26 13%
Student > Bachelor 23 12%
Student > Ph. D. Student 16 8%
Student > Postgraduate 16 8%
Other 43 22%
Unknown 47 24%
Readers by discipline Count As %
Medicine and Dentistry 82 41%
Nursing and Health Professions 11 6%
Neuroscience 11 6%
Agricultural and Biological Sciences 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Other 20 10%
Unknown 61 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2021.
All research outputs
#1,783,385
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,807
of 11,499 outputs
Outputs of similar age
#14,727
of 207,187 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 268 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.